|
Market Closed -
Nasdaq
21:00:00 15/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.3213 USD | +4.90% |
|
-6.82% | -67.87% |
| 09-02 | Needham Downgrades TScan Therapeutics to Hold From Buy | MT |
| 09-02 | Wedbush Downgrades TScan Therapeutics to Neutral From Outperform, Adjusts Price Target to $1 From $5 | MT |
| Market Cap | 21.78M 18.86M 17.84M 16.15M 30.31M 2.09B 30.54M 213M 81.89M 1.06B 81.8M 79.99M 3.38B | P/E 2026 * |
-0.4x | P/E 2027 * | -0.54x |
|---|---|---|---|---|---|
| Enterprise Value | -77.09M -66.78M -63.14M -57.17M -107M -7.39B -108M -754M -290M -3.75B -290M -283M -11.96B | EV / Sales 2026 * |
-17.1x | EV / Sales 2027 * | -16.2x |
| Free-Float |
93.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TCRX | Delayed | |
CBOE
| TCRX | Real-time |
Last Transcript: TScan Therapeutics, Inc.
| 1 day | +4.90% | ||
| 1 week | -6.82% | ||
| Current month | -55.97% | ||
| 1 month | -58.74% | ||
| 3 months | -66.19% | ||
| 6 months | -69.40% | ||
| Current year | -67.87% |
| 1 week | 0.29 |  | 0.35 |
| 1 month | 0.29 | | 0.84 |
| Current year | 0.29 | | 1.47 |
| 1 year | 0.29 | | 2.57 |
| 3 years | 0.29 | | 9.69 |
| 5 years | 0.29 | | 9.69 |
| 10 years | 0.29 | | 14.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin MacBeath
CEO | Chief Executive Officer | 56 | 27/03/2023 |
Dawn Pinchasik
CTO | Chief Tech/Sci/R&D Officer | - | 05/02/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Katina Dorton
BRD | Director/Board Member | 68 | 22/03/2021 |
Gavin MacBeath
BRD | Director/Board Member | 56 | 23/05/2023 |
Stephen Biggar
CHM | Chairman | 55 | 11/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/05/26 | Free | Director | 67,000 | 0.1200% | ||
| 20/05/26 | Free | Director | 67,000 | 0.1200% | ||
| 20/05/26 | Free | Director | 67,000 | 0.1200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.90% | -6.82% | -80.99% | -88.88% | 21.78M | |
| -1.38% | +0.20% | +46.42% | +96.33% | 69.18B | |
| -0.49% | -1.25% | +35.49% | +75.01% | 62B | |
| -4.29% | -3.98% | -16.22% | +350.66% | 26.19B | |
| +1.46% | +2.25% | +28.84% | +14.54% | 25.75B | |
| -2.20% | -2.00% | -1.22% | -14.48% | 24.29B | |
| +3.74% | +4.73% | +25.95% | -14.14% | 19.84B | |
| +1.26% | -14.23% | +170.04% | +298.75% | 15.65B | |
| -5.54% | +0.69% | -8.13% | +830.48% | 13.88B | |
| -0.39% | -4.24% | -9.86% | +454.94% | 14.09B | |
| Average | -0.29% | -2.66% | +19.03% | +200.32% | 27.09B | |
| Weighted average by Cap. | -0.90% | -1.32% | +31.83% | +158.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.51M 3.9M 3.69M 3.34M 6.27M 432M 6.32M 44.04M 16.94M 219M 16.92M 16.55M 699M | 3.28M 2.84M 2.68M 2.43M 4.56M 314M 4.59M 32.03M 12.32M 159M 12.31M 12.04M 508M |
| Net income | -105M -90.83M -85.89M -77.76M -146M -10.06B -147M -1.02B -394M -5.1B -394M -385M -16.27B | -79.1M -68.52M -64.79M -58.66M -110M -7.59B -111M -773M -297M -3.85B -297M -291M -12.27B |
| Net Debt | -98.87M -85.64M -80.98M -73.31M -138M -9.48B -139M -966M -372M -4.81B -371M -363M -15.34B | -74.76M -64.75M -61.23M -55.43M -104M -7.17B -105M -731M -281M -3.64B -281M -275M -11.6B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/09/26 | US$0.3213 | +4.90% | 679,168 |
| 14/09/26 | US$0.3063 | -4.40% | 1,103,954 |
| 11/09/26 | US$0.3204 | +0.79% | 873,124 |
| 10/09/26 | US$0.3179 | -3.70% | 804,593 |
| 09/09/26 | US$0.3301 | -4.26% | 704,849 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TCRX Stock
Select your edition
All financial news and data tailored to specific country editions
